{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:17Z","timestamp":1790899457712,"version":"4.1.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center for AIDS Research, University of Rochester","award":["4P30AI078498-09"],"award-info":[{"award-number":["4P30AI078498-09"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergies and Infectious Diseases","doi-asserted-by":"crossref","award":["K23 AI108355"],"award-info":[{"award-number":["K23 AI108355"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA14211 and DA42985"],"award-info":[{"award-number":["DA14211 and DA42985"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","award":["Troup Fund"],"award-info":[{"award-number":["Troup Fund"]}],"id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231467","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:36:25Z","timestamp":1587144985000},"page":"e0231467","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Toward precision prescribing for methadone: Determinants of methadone deposition"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-7515","authenticated-orcid":true,"given":"Andrew H.","family":"Talal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-9513","authenticated-orcid":true,"given":"Charles S.","family":"Venuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Chakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene D.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianthi","family":"Markatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"pone.0231467.ref001","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride","volume":"193","author":"VP Dole","year":"1965","journal-title":"JAMA"},{"key":"pone.0231467.ref002","first-page":"122","article-title":"Narcotic blockade\u2014a medical technique for stopping heroin use by addicts","volume":"79","author":"VP Dole","year":"1966","journal-title":"Trans Assoc Am Physicians"},{"key":"pone.0231467.ref003","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.ADM.0000435321.39251.d7","article-title":"Safe methadone induction and stabilization: report of an expert panel","volume":"7","author":"LE Baxter","year":"2013","journal-title":"J Addict Med"},{"key":"pone.0231467.ref004","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","article-title":"Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society","volume":"15","author":"R Chou","year":"2014","journal-title":"J Pain"},{"key":"pone.0231467.ref005","unstructured":"Alderks CE. Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities: 2003\u20132015 (Update). The CBHSQ Report. Rockville (MD)2013. p. 1\u20138."},{"key":"pone.0231467.ref006","doi-asserted-by":"crossref","first-page":"l45","DOI":"10.1016\/0024-3205(94)00937-6","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine","volume":"56","author":"K Kristensen","year":"1995","journal-title":"Life Sci"},{"key":"pone.0231467.ref007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","article-title":"The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord","volume":"223","author":"AL Gorman","year":"1997","journal-title":"Neurosci Lett"},{"key":"pone.0231467.ref008","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1369-1600.2011.00349.x","article-title":"CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction","volume":"18","author":"O Levran","year":"2013","journal-title":"Addict Biol"},{"key":"pone.0231467.ref009","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jcph.1405","article-title":"Drug-drug interaction studies of methadone and antiviral drugs: Lessons learned","volume":"59","author":"IR Younis","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"pone.0231467.ref010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation","volume":"108","author":"Y Chang","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"pone.0231467.ref011","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ALN.0000000000000867","article-title":"Methadone pharmacogenetics: CYP2B6 polymorphisms determine plasma concentrations, clearance, and metabolism","volume":"123","author":"ED Kharasch","year":"2015","journal-title":"Anesthesiology"},{"key":"pone.0231467.ref012","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jcph.1","article-title":"Role of cytochrome P4502B6 in methadone metabolism and clearance","volume":"53","author":"ED Kharasch","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"pone.0231467.ref013","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2014metabolism, pharmacokinetics and interactions","volume":"50","author":"A Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"pone.0231467.ref014","doi-asserted-by":"crossref","first-page":"e19527","DOI":"10.1371\/journal.pone.0019527","article-title":"Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response","volume":"6","author":"F Fonseca","year":"2011","journal-title":"PLoS One"},{"key":"pone.0231467.ref015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/dmd.112.050625","article-title":"Methadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6","volume":"41","author":"S Gadel","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"pone.0231467.ref016","doi-asserted-by":"crossref","first-page":"e86114","DOI":"10.1371\/journal.pone.0086114","article-title":"Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis","volume":"9","author":"BB Dennis","year":"2014","journal-title":"PLoS One"},{"key":"pone.0231467.ref017","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014","volume":"108","author":"JE Zibbell","year":"2018","journal-title":"Am J Public Health"},{"key":"pone.0231467.ref018","volume-title":"Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"pone.0231467.ref019","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma: recent trends in the United States","volume":"127","author":"HB El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"pone.0231467.ref020","first-page":"20","article-title":"Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review","author":"T Kanda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0231467.ref021","doi-asserted-by":"crossref","first-page":"e0462","DOI":"10.1097\/MD.0000000000010462","article-title":"Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis","volume":"97","author":"R Mohr","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"pone.0231467.ref022","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3748\/wjg.v24.i11.1269","article-title":"Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals","volume":"24","author":"M Noureddin","year":"2018","journal-title":"World J Gastroenterol"},{"key":"pone.0231467.ref023","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"A Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"pone.0231467.ref024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"UM Zanger","year":"2013","journal-title":"Front Genet"},{"key":"pone.0231467.ref025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10826089409047374","article-title":"Phases of treatment: a practical approach to methadone maintenance treatment","volume":"29","author":"ET Moolchan","year":"1994","journal-title":"Int J Addict"},{"key":"pone.0231467.ref026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2125.2001.00342.x","article-title":"The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz","volume":"51","author":"SM Clarke","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0231467.ref027","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/clpt.2011.276","article-title":"Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics","volume":"91","author":"ED Kharasch","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0231467.ref028","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/dmd.32.3.348","article-title":"Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers","volume":"32","author":"SR Faucette","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"pone.0231467.ref029","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.12.009","article-title":"Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity","volume":"101","author":"ED Kharasch","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"pone.0231467.ref030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"RA Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"pone.0231467.ref031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"DR Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"pone.0231467.ref032","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAI.0b013e3181d3cad3","article-title":"Pharmacokinetic interactions between buprenorphine\/naloxone and once-daily lopinavir\/ritonavir","volume":"54","author":"RD Bruce","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0231467.ref033","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11894-014-0372-6","article-title":"Utilization of FibroScan in clinical practice","volume":"16","author":"A Bonder","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"key":"pone.0231467.ref034","first-page":"17654","article-title":"Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysis","volume":"8","author":"Y Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"pone.0231467.ref035","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"L Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"pone.0231467.ref036","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","author":"European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado","year":"2015","journal-title":"J Hepatol"},{"key":"pone.0231467.ref037","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/jgh.12134","article-title":"Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance","volume":"28","author":"M Kumar","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"pone.0231467.ref038","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"T Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"pone.0231467.ref039","doi-asserted-by":"crossref","first-page":"e0200656","DOI":"10.1371\/journal.pone.0200656","article-title":"Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study","volume":"13","author":"N Fabrellas","year":"2018","journal-title":"PLoS One"},{"key":"pone.0231467.ref040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/cpt.1477","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy","volume":"106","author":"Z Desta","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0231467.ref041","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/978-3-642-04898-2_420","volume-title":"International encyclopedia of statistical sciencee","author":"JD Gibbons","year":"2011"},{"key":"pone.0231467.ref042","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/001316446602600307","article-title":"Note on rank biserial correlation","volume":"26","author":"GV Glass","year":"1966","journal-title":"Educ Psychol Meas"},{"key":"pone.0231467.ref043","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02289138","article-title":"Rank-biserial correlation","volume":"21","author":"EE Cureton","year":"1956","journal-title":"Psychometrika"},{"key":"pone.0231467.ref044","doi-asserted-by":"crossref","DOI":"10.1002\/0471725250","volume-title":"Robust statistics","author":"PJ Huber","year":"1981"},{"key":"pone.0231467.ref045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2018.00212","article-title":"From CD4-Based Initiation to Treating All HIV-Infected Adults Immediately: An Evidence-Based Meta-analysis","volume":"9","author":"A Song","year":"2018","journal-title":"Front Immunol"},{"key":"pone.0231467.ref046","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/dmd.115.064352","article-title":"Differences in Methadone Metabolism by CYP2B6 Variants","volume":"43","author":"S Gadel","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"pone.0231467.ref047","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/jcph.1427","article-title":"Methadone Disposition: Implementing Lessons Learned","volume":"59","author":"ED Kharasch","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"pone.0231467.ref048","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bcp.12576","article-title":"Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity","volume":"79","author":"S Mouly","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0231467.ref049","unstructured":"US Food and Drug Administration. DOLOPHINE\u00ae (methadone hydrochloride) tablets 2018 [Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/006134s045lbl.pdf"},{"key":"pone.0231467.ref050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19","volume":"16","author":"JG Gerber","year":"2004","journal-title":"Chirality"},{"key":"pone.0231467.ref051","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"S Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0231467.ref052","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/JCP.0b013e318222b5dd","article-title":"CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer","volume":"31","author":"SC Wang","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"pone.0231467.ref053","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cpt.690","article-title":"Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects","volume":"102","author":"Y Zhou","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0231467.ref054","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.fpc.0000189797.03845.90","article-title":"Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz","volume":"16","author":"J Wang","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"pone.0231467.ref055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1515\/dmdi-2012-0027","article-title":"Cytochrome P450 2B6: function, genetics, and clinical relevance","volume":"27","author":"M Turpeinen","year":"2012","journal-title":"Drug Metabol Drug Interact"},{"key":"pone.0231467.ref056","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/pgs.11.160","article-title":"Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV\/AIDS treatment","volume":"13","author":"J Li","year":"2012","journal-title":"Pharmacogenomics"},{"key":"pone.0231467.ref057","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejps.2006.04.004","article-title":"Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese","volume":"29","author":"S Guan","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"pone.0231467.ref058","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00008571-200310000-00005","article-title":"Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6","volume":"13","author":"J Kirchheiner","year":"2003","journal-title":"Pharmacogenetics"},{"key":"pone.0231467.ref059","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"S Crettol","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0231467.ref060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7326\/M18-2357","article-title":"Cases in precision medicine: The role of pharmacogenetics in precision prescribing","volume":"170","author":"B Lin","year":"2019","journal-title":"Ann Intern Med"},{"key":"pone.0231467.ref061","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","article-title":"Genetic analyses of diverse populations improves discovery for complex traits","volume":"570","author":"GL Wojcik","year":"2019","journal-title":"Nature"},{"key":"pone.0231467.ref062","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00194951","article-title":"Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts","volume":"48","author":"JW de Vos","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0231467.ref063","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","article-title":"Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients","volume":"50","author":"DJ Foster","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0231467.ref064","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jat\/27.6.332","article-title":"Methadone and metabolite urine concentrations in patients maintained on methadone","volume":"27","author":"KL Preston","year":"2003","journal-title":"J Anal Toxicol"},{"key":"pone.0231467.ref065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09540261.2018.1509843","article-title":"Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment","volume":"30","author":"NJ Schlienz","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"pone.0231467.ref066","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/cpdd.336","article-title":"Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment","volume":"6","author":"AH Talal","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"pone.0231467.ref067","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3325\/cmj.2018.59.298","article-title":"Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study","volume":"59","author":"Z Kljucevic","year":"2018","journal-title":"Croat Med J"},{"key":"pone.0231467.ref068","doi-asserted-by":"crossref","first-page":"e69310","DOI":"10.1371\/journal.pone.0069310","article-title":"Hepatitis C virus infection influences the S-methadone metabolite plasma concentration","volume":"8","author":"SL Wu","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T12:50:34Z","timestamp":1615294234000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231467"}},"subtitle":[],"editor":[{"given":"Wenyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231467","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]}}}